MedinCell announces three new products entering regulatory development
February 2, 2021
Covid-19: MedinCell presents positive first results from the clinical trial aiming at validating the safety of continuous administration of Ivermectin
December 17, 2020
MedinCell initiates the first clinical trial of its Covid-19 prevention program
September 29, 2020
MedinCell launches Regulatory Development of mdc-WWM Program
April 22, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
April 6, 2020
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
March 25, 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
January 13, 2020
MedinCell receives $19 million grant for its mdc-WWM program
November 28, 2019
MedinCell announces that mdc-CWM progresses as planned
September 25, 2019
Long-acting injectable antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities
August 26, 2019
